Key Points from the Announcement
- NutryFarm International Limited has signed an amended and restated Share Conversion Agreement (“SCA”) with Corpbond IV Ltd, effectively replacing the previous agreement.
- The Company has also terminated two loan agreements related to a US\$1 million loan facility with its subsidiary, AI Nova Pte. Ltd. and lender Pan Dai, as the funds were not disbursed and financing will not proceed.
- NutryFarm International was discharged from judicial management on 2 February 2026, and the Board is now fully authorized to act on behalf of the Company.
- The Long-Stop Date for completion of share conversion arrangements has been extended to 31 December 2026, providing additional time for restructuring and satisfaction of key conditions precedent.
- Termination of the loan agreements has no material impact on the Group’s consolidated earnings per share or net tangible assets for the financial year ending 30 September 2026.
- The Company’s shares remain suspended from trading since 11 April 2022; investors are advised to exercise caution.
Detailed Article for Investors
NutryFarm International Limited (the “Company”) has made two significant announcements that are likely to influence investor sentiment and may impact the share price once trading resumes.
1. Amended and Restated Share Conversion Agreement with Corpbond IV Ltd
The Company has entered into an amended SCA with Corpbond IV Ltd on 28 July 2026. This new agreement replaces the original share conversion agreement signed on 28 October 2025. The key motivations for this restatement are:
- Discharge from Judicial Management: As of 2 February 2026, NutryFarm is no longer under judicial management. The Board is now the authorized decision-maker, with all roles previously played by the Judicial Manager now reverted to the Board.
- Extension of Long-Stop Date: The deadline for completing the share conversion and related restructuring steps has been extended from 31 December 2025 to 31 December 2026, or a later date as mutually agreed. This allows more time for satisfying the conditions required for the restructuring.
- Protective Provisions: Any indemnification and limitation of liability provisions for the Judicial Manager from the original agreement are maintained and remain binding.
Why This Matters: The extension and restatement reflect substantial changes in the Company’s circumstances and legal status. The Board’s full authority and extended timeline may provide greater clarity and stability to the restructuring process. Successful completion of the SCA and related transactions could have a material impact on the Company’s capital structure and future prospects.
2. Termination of US\$1 Million Loan Agreements
The Company’s subsidiary, AI Nova Pte. Ltd., and lender Pan Dai have mutually agreed to terminate a US\$1 million loan facility and related conversion agreement. The loan was never disbursed, and both sides have confirmed the financing will not proceed.
- All obligations and rights under these agreements have been fully cancelled, with no outstanding payments, claims, or liabilities between the parties.
- Financial Impact: The termination is not expected to have any material effect on the Group’s consolidated earnings per share or net tangible assets for the current financial year.
3. Other Important Shareholder Information
- No new directors will be appointed as a result of the SCA, and no new service agreements are being entered into.
- No director, controlling shareholder, or their associates have any interest in the SCA, apart from their shareholdings in the Company.
- A circular to shareholders, including further details and an EGM notice, will be dispatched in due course.
- Cautionary Guidance: Completion of the SCA and related transactions is subject to fulfillment of certain conditions precedent. There is no certainty that all transactions will be completed.
- The Company will provide updates on material developments via SGXNET. Trading in the Company’s shares remains suspended since 11 April 2022.
Potential Price-Sensitive Aspects
- Removal from judicial management and enhanced Board authority may positively influence market confidence if trading resumes.
- Extension of the restructuring timeline could be viewed as both a positive (more time for proper completion) and a negative (potential delay in value realization).
- Termination of the loan agreements removes any risk or potential dilution associated with the US\$1 million facility.
- Investors should note the ongoing trading suspension and uncertain timeline for resumption.
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Investors should consult their financial advisers before making any investment decisions. The completion of the transactions discussed is subject to various conditions precedent and there is no certainty that they will be completed. The Company’s shares remain suspended and investors are advised to exercise caution.
